login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
AXOGEN INC (AXGN) Stock News
USA
- NASDAQ:AXGN -
US05463X1063
-
Common Stock
17.49
USD
+0.52 (+3.06%)
Last: 10/21/2025, 8:00:00 PM
17.49
USD
0 (0%)
After Hours:
10/21/2025, 8:00:00 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
AXGN Latest News, Press Relases and Analysis
All
Press Releases
4 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
7 days ago - By: Axogen, Inc.
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
7 days ago - By: Axogen, Inc.
Axogen, Inc. to Report 2025 Third Quarter Financial Results on October 29, 2025
9 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
14 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
2 months ago - By: Stocktwits
Why Is Axogen Stock Down 11% In Pre-Market Today?
3 months ago - By: The Motley Fool
Axogen (AXGN) Q2 Revenue Jumps 18%
3 months ago - By: Axogen, Inc.
Axogen, Inc. Reports Second Quarter 2025 Financial Results
19 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
21 days ago - By: DJS Law Group
Axogen, Inc. Investigated for Securities Fraud Violations - Contact the DJS Law Group to Discuss Your Rights – AXGN
21 days ago - By: The Schall Law Firm
AXGN Investors Have Opportunity to Join Axogen, Inc. Fraud Investigation with the Schall Law Firm
24 days ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
3 months ago - By: Benzinga
- Mentions:
AFG
CXDO
YUM
PACK
...
Earnings Scheduled For August 5, 2025
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
a month ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
2 months ago - By: Pomerantz LLP
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Axogen, Inc. - AXGN
2 months ago - By: Zacks Investment Research
Does AxoGen (AXGN) Have the Potential to Rally 53.1% as Wall Street Analysts Expect?
2 months ago - By: Axogen, Inc.
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
2 months ago - By: Axogen, Inc.
Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences
2 months ago - By: Benzinga
- Mentions:
EPIX
THAR
NXL
IPA
...
12 Health Care Stocks Moving In Monday's Intraday Session
2 months ago - By: Investor's Business Daily
Why Axogen Stock, Up 76% Over The Last Two Months, Just Plummeted
2 months ago - By: Axogen, Inc.
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
2 months ago - By: Axogen, Inc.
Axogen Provides Update on FDA Review Timeline for Avance Nerve Graft
2 months ago - By: Yahoo Finance
Axogen (AXGN) Slid on a Weaker Than Expected Gross Margin
2 months ago - By: Yahoo Finance
- Mentions:
RJF
Raymond James Slashes PT on Axogen (AXGN) to $20 From $21
2 months ago - By: Zacks Investment Research
Wall Street Analysts Predict a 76.37% Upside in AxoGen (AXGN): Here's What You Should Know
3 months ago - By: Zacks Investment Research
- Mentions:
PRCT
AxoGen (AXGN) Beats Q2 Earnings and Revenue Estimates
3 months ago - By: Axogen, Inc.
Axogen, Inc. Reports Second Quarter 2025 Financial Results
3 months ago - By: Axogen, Inc.
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
3 months ago - By: Axogen, Inc.
Axogen, Inc. to participate at the Canaccord Genuity 45th Annual Growth Conference
3 months ago - By: Zacks Investment Research
- Mentions:
IDXX
AxoGen (AXGN) Earnings Expected to Grow: Should You Buy?
Please enable JavaScript to continue using this application.